- Home
- VGZ vs GALT Comparison
VGZ vs GALT Comparison
Compare VGZ & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VGZ | GALT |
|---|---|---|
| Founded | 1983 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.5M | 297.0M |
| IPO Year | 1996 | 2008 |
Fundamental Metrics
Financial Performance| Metric | VGZ | GALT |
|---|---|---|
| Price | $2.17 | $3.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $3.75 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 952.0K | 323.5K |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.43 | $2.03 |
| 52 Week High | $3.13 | $7.13 |
Technical Indicators
Market Signals| Indicator | VGZ | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 49.77 | 49.98 |
| Support Level | $2.06 | $2.74 |
| Resistance Level | $2.36 | $4.35 |
| Average True Range (ATR) | 0.10 | 0.33 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 29.59 | 28.07 |
Price Performance
Historical ComparisonAbout VGZ Vista Gold Corp
Vista Gold Corp operates as a development-stage company in the gold mining industry. Its flagship asset is the Mt Todd Gold Project, a development-stage gold deposit located in the Tier-1 jurisdiction of Northern Territory, Australia. Mt Todd offers a large gold mineral reserve, development optionality, expansion opportunities, exploration upside, local infrastructure, community support, and demonstrated economic feasibility. It operates in one reportable segment, consisting of acquisition, exploration and evaluation activities which are focused on Australia.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.